Indiana Poison Center reports GLP-1 calls doubled last year; National Poison Data System, America's Poison Centers reports a ...

As doctors learn why GLP-1s don't work for about 50% of people, they are also learning more about the complex drivers of ...

Some patients have pointed to severe undisclosed side effects, including blindness, loss of brain function and organ damage.

Association driven by fewer major amputations ...

GLP-1 weight-loss drugs offer promising results but come with potential risks and unknown long-term effects, emphasizing the ...

Kayshild is recommended for adults with non-cirrhotic metabolic dysfunction-associated steatohepatitis and ...

Amgen may not have an approved GLP-1 treatment just yet, but that could change in the future.

Lawsuits continue against makers of GLP-1 weight-loss drugs over side effects ranging from extreme vomiting to what some ...

A cohort study of liver transplant candidates with HCC suggested that local-regional therapy with yttrium-90 transarterial ...

Winfrey has openly discussed her weight-loss journey and the use of prescription GLP-1 medications in recent years.

Poison control calls involving GLP-1 medications like semaglutide and tirzepatide have dramatically risen in recent years.

With more studies emerging, GLP-1 and dual GIP/GLP-1 medications have become well-established options for those with obesity ...